View in EDS HTML Full Text PDF Full Text

Quantification of increased biologically active CXCL12α plasma concentrations after ACKR3 antagonist treatment in humans.

Saved in:
Bibliographic Details
Title: Quantification of increased biologically active CXCL12α plasma concentrations after ACKR3 antagonist treatment in humans.
Authors: Blattmann, Peter1 (AUTHOR) peter.blattmann@idorsia.com, Farine, Hervé1 (AUTHOR), Dan, Brian1 (AUTHOR), Stiffler, Nicole1 (AUTHOR), Lefebvre, Thomas1 (AUTHOR), Huynh, Christine1 (AUTHOR), Sidharta, Patricia N.1 (AUTHOR), Dingemanse, Jasper1 (AUTHOR), Welford, Richard W. D.1 (AUTHOR), Keller, Marcel1 (AUTHOR), Strasser, Daniel S.1 (AUTHOR) daniel.strasser@idorsia.com
Source: CTS: Clinical & Translational Science. Feb2024, Vol. 17 Issue 2, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.13708